Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moudgil

Showing results (631-640 of 644) with videos related to

Pageof 65
Sort By:
Molecular Therapy Oncolytics|February 22, 2021
HDAC inhibition prevents transgene expression downregulation and loss-of-function in T-cell-receptor-transduced T cellsTamson V Moore, Gina M Scurti, Matthew DeJong, et al.
Hepatology (Baltimore, Md.)|April 2, 2019
Hepatocyte Nuclear Factor 4-Alpha Is Essential for the Active Epigenetic State at Enhancers in Mouse LiverAvinash Thakur, Jasper C H Wong, Evan Y Wang, et al.
Seminars in Oncology|November 16, 2010
Signaling through OX40 enhances antitumor immunityShawn M Jensen, Levi D Maston, Michael J Gough, et al.
Cancer Research|November 2, 2013
OX40 is a potent immune-stimulating target in late-stage cancer patientsBrendan D Curti, Magdalena Kovacsovics-Bankowski, Nicholas Morris, et al.
Current Molecular Medicine|August 20, 2009
Cancer immunotherapy: the role regulatory T cells play and what can be done to overcome their inhibitory effectsUlf Petrausch, Christian H Poehlein, Shawn M Jensen, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 13, 2012
Renal function and proteinuria after successful immunosuppressive therapies in patients with FSGSRonald J Hogg, Aaron Friedman, Tom Greene, et al.
Research Square|May 4, 2026
Contemporary Treatment Responses of Recurrent Focal Segmental Glomerulosclerosis or Steroid Resistant Nephrotic Syndrome in Children after Kidney Transplantation: Phase 2 of a Multicenter Electronic Health Record Data AnalysisVikas R Dharnidharka, Asha Moudgil, Priya S Verghese, et al.
The American Journal of Cardiology|September 29, 2020
Temporal Trends of Cardiac Outcomes and Impact on Survival in Patients With CancerMuzna Hussain, Yuan Hou, Chris Watson, et al.
Cancer Research Communications|May 8, 2026
Novel Mechanism of and Therapeutic Approach for Anthracycline-Induced Cardiotoxicity (AIC)Qingzhu Wang, Wanying Zhang, Josephine Chen, et al.
Cardio-Oncology (London, England)|December 9, 2020
Perspectives on the COVID-19 pandemic impact on cardio-oncology: results from the COVID-19 International Collaborative Network surveyDiego Sadler, Jeanne M DeCara, Joerg Herrmann, et al.
Pageof 65

Showing results (631-640 of 644) with videos related to

Sort By:
Pageof 65
Molecular Therapy Oncolytics|February 22, 2021
HDAC inhibition prevents transgene expression downregulation and loss-of-function in T-cell-receptor-transduced T cellsTamson V Moore, Gina M Scurti, Matthew DeJong, et al.
Hepatology (Baltimore, Md.)|April 2, 2019
Hepatocyte Nuclear Factor 4-Alpha Is Essential for the Active Epigenetic State at Enhancers in Mouse LiverAvinash Thakur, Jasper C H Wong, Evan Y Wang, et al.
Seminars in Oncology|November 16, 2010
Signaling through OX40 enhances antitumor immunityShawn M Jensen, Levi D Maston, Michael J Gough, et al.
Cancer Research|November 2, 2013
OX40 is a potent immune-stimulating target in late-stage cancer patientsBrendan D Curti, Magdalena Kovacsovics-Bankowski, Nicholas Morris, et al.
Current Molecular Medicine|August 20, 2009
Cancer immunotherapy: the role regulatory T cells play and what can be done to overcome their inhibitory effectsUlf Petrausch, Christian H Poehlein, Shawn M Jensen, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 13, 2012
Renal function and proteinuria after successful immunosuppressive therapies in patients with FSGSRonald J Hogg, Aaron Friedman, Tom Greene, et al.
Research Square|May 4, 2026
Contemporary Treatment Responses of Recurrent Focal Segmental Glomerulosclerosis or Steroid Resistant Nephrotic Syndrome in Children after Kidney Transplantation: Phase 2 of a Multicenter Electronic Health Record Data AnalysisVikas R Dharnidharka, Asha Moudgil, Priya S Verghese, et al.
The American Journal of Cardiology|September 29, 2020
Temporal Trends of Cardiac Outcomes and Impact on Survival in Patients With CancerMuzna Hussain, Yuan Hou, Chris Watson, et al.
Cancer Research Communications|May 8, 2026
Novel Mechanism of and Therapeutic Approach for Anthracycline-Induced Cardiotoxicity (AIC)Qingzhu Wang, Wanying Zhang, Josephine Chen, et al.
Cardio-Oncology (London, England)|December 9, 2020
Perspectives on the COVID-19 pandemic impact on cardio-oncology: results from the COVID-19 International Collaborative Network surveyDiego Sadler, Jeanne M DeCara, Joerg Herrmann, et al.
Pageof 65